Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Neuronetics, Inc.STIM · Entity 6248 | VP of Commercial Access | March 10, 2020 | March 11, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Neuronetics, Inc.
Report date March 10, 2020 · Filed March 11, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 65,987 |
Reported balance
After 2020-03-10 transaction · row 1
1 source rowRow 1 · 2020-03-10 · Tax withholding · Disposed 898 · Balance 65,987 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 10, 2020 Filed Mar 11, 2020 21:34 UTC | Neuronetics, Inc. STIM · Entity 6248 | Tax withholdingCommon Stock | 898 | $1.98 | $1,778.04 |
DisclosureSEC source: 0001192482-20-000216 · edgar.xml · nonDerivative · entry 1 Tropsha Yelena · CIK 0001744954 · VP of Commercial Access 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,987 Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 21:44 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 38,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-20-000200 · edgar.xml · nonDerivative · entry 1 Tropsha Yelena · CIK 0001744954 · VP of Commercial Access 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,885 F1 · shares: Represents a restricted stock unit ("RSU") award of which 1/3 vests on each of the first, second and third anniversaries of the date of grant, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 15, 2020 Filed Jan 17, 2020 21:26 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 19,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-003994 · doc4.xml · nonDerivative · entry 1 Tropsha Yelena · CIK 0001744954 · VP of Commercial Access 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,135 F1 · shares: One-third (1/3rd) of the shares subject to the restricted stock unit ("RSU") grant shall vest on each of January 15, 2021, January 15, 2022 and January 15, 2023, subject to Reporting Person continuing to provide service through each such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 23:15 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantEmployee Stock Option (right to buy) · Derivative | 16,077 | $0.00 Strike: $16.42 | $0.00 |
DisclosureSEC source: 0001209191-19-018614 · doc4.xml · derivative · entry 2 Tropsha Yelena · CIK 0001744954 · VP of Commercial Access 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,077 Underlying: Common Stock · 16,077 shares Expires 2029-03-08 F3 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on March 8, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 23:15 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 9,135 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-018614 · doc4.xml · nonDerivative · entry 1 Tropsha Yelena · CIK 0001744954 · VP of Commercial Access 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,135 F1 · shares: Twenty-five percent (25%) of the shares subject to the restricted stock unit ("RSU") grant shall vest on each of March 8, 2020 and March 8, 2021, and fifty percent (50%) of the shares subject to the RSU grant shall vest on March 8, 2022, subject to Reporting Person continuing to provide service through each such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.